XML 51 R32.htm IDEA: XBRL DOCUMENT
v3.21.1

Collaboration, License, and Other Agreements - Sanofi, Antibody Narrative (Details) |  | 3 Months Ended
--- | --- | ---
Apr. 01, 2020 | Mar. 31, 2021
Sanofi Collaboration Agreement, Antibody | Minimum |  |
Disaggregation of Revenue [Line Items] |  |
Percentage of trial costs required to be funded by collaborating party |  | 80.00%
Sanofi Collaboration Agreement, Antibody | Maximum |  |
Disaggregation of Revenue [Line Items] |  |
Percentage of trial costs required to be funded by collaborating party |  | 100.00%
Praluent Agreement |  |
Disaggregation of Revenue [Line Items] |  |
Royalty percentage to be received on net product sales outside of the United States | 5.00% |
Percentage of damages company is responsible for | 50.00% |
Praluent Agreement | Sanofi |  |
Disaggregation of Revenue [Line Items] |  |
Percentage of royalty payment that can be used to offset litigation proceedings | 50.00% |

X
- Definition Loss Contingency, Percentage Of Damages Responsible For + References No definition available. + Details
Name: | regn_LossContingencyPercentageOfDamagesResponsibleFor
Namespace Prefix: | regn_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage Of Royalty Payment That Can Be Offset + References No definition available. + Details
Name: | regn_PercentageOfRoyaltyPaymentThatCanBeOffset
Namespace Prefix: | regn_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of Trial Costs Required To Be Funded By Collaborating Party + References No definition available. + Details
Name: | regn_PercentageOfTrialCostsRequiredToBeFundedByCollaboratingParty
Namespace Prefix: | regn_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalty Percentage To Be Received On Net Product Sales Outside Of United States + References No definition available. + Details
Name: | regn_RoyaltyPercentageToBeReceivedOnNetProductSalesOutsideOfUnitedStates
Namespace Prefix: | regn_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=regn_SanofiCollaborationAgreementAntibodyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=regn_PraluentCrossLicenseAndCommercializationAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=regn_SanofiMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |